FLO-PRED (prednisolone acetate) Taro Patent: 6,399,079 Expiration: Jun 3, 2018 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or…
Posts published in “Patent Expiration”
Annual Drug Patent Expirations for ADCIRCA Adcirca is a drug marketed by Eli Lilly Co and is included in one NDA. It is available from three suppliers. There are three…
Annual Drug Patent Expirations for CIALIS Cialis is a drug marketed by Lilly and is included in one NDA. It is available from eight suppliers. There are four patents protecting…
SKLICE (ivermectin) Arbor pharms llc Patent: 6,103,248 Expiration: May 22, 2018 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com…
Annual Drug Patent Expirations for BOSULIF Bosulif is a drug marketed by Pf Prism Cv and is included in one NDA. It is available from two suppliers. There are five…
Annual Drug Patent Expirations for TOPICORT Topicort is a drug marketed by Taro and is included in ten NDAs. It is available from three suppliers. There are three patents protecting…
Annual Drug Patent Expirations for CLOBEX Clobex is a drug marketed by Galderma Labs Lp and Galderma Labs and is included in three NDAs. It is available from five suppliers.…
Annual Drug Patent Expirations for ALTOPREV Altoprev is a drug marketed by Covis Pharma Bv and is included in one NDA. It is available from one supplier. There is one…
Annual Drug Patent Expirations for REBETOL Rebetol is a drug marketed by Merck Sharp Dohme and Schering and is included in two NDAs. It is available from one supplier. There…
Annual Drug Patent Expirations for REBETOL Rebetol is a drug marketed by Merck Sharp Dohme and Schering and is included in two NDAs. It is available from one supplier. There…
